| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Outline of Final Research Achievements |
My research project were focused and continued to establish the regenerative medicine in the field of cardiovascular diseases. In particular, development of myocardial regeneration therapy and for severe heart failure and vascularization therapy for severe peripheral limb ischemia had been conducted. In addition, the functional analysis of surplus cells in clinical regenerative trial, animal experiments have been conducted simultaneously to establish elite stem cells that are optimal for regenerative medicine and to elucidate their mechanisms.
|
